A.CATRIN PHARMA
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
26-08
micro format · 26 days late
2025
29-08
micro format · 29 days late
2024
02-04
Gazette deed
IncorporationStarting capital €3,000 · Appointment: CATRIN Anne Ghislaine (director) · Founder11 points ▸
Gazette deed
Incorporation
Starting capital €3,000 · Appointment: CATRIN Anne Ghislaine (director) · Founder11 points ▸
- Incorporation, 28-03-2024
- Founder, CATRIN Anne Ghislaine (comparante)
- Founding capital, €3,000
- Bank account, 3000, “compte spécial ouvert au nom de la société en formation” (deed in French)
- Other provision, “avantages particuliers attribués à un fondateur ou à une personne ayant participé directement ou indirectement à la constitution” (deed in French)
- Other provision, “dépôt des apports effectué conformément à la loi”, 3000 (deed in French)
- Capital
- Other provision, “condition suspensive décisions transitoires, décisions suivantes effectives seulement à dater et sous condition suspensive dépôt extrait acte constitutif au gre…” (deed in French)
- Registered office clause, “6120 Ham-sur-Heure, rue de Marbaix, 18 A” (deed in French)
- Director appointment, CATRIN Anne Ghislaine (director)
- Pre-incorporation commitments, “takeover”, 01-01-2024 (deed in French)
Gazette deedNBB filing
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
On 28 March 2024, A.CATRIN PHARMA was incorporated as a private limited company by one natural person, with a starting capital of €3,000.12 CATRIN Anne Ghislaine is director of the company, appointed in the act of 02-04-2024.2 The company has filed 2 sets of annual accounts, the latest for financial year 2025.3